Clinical trial
CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
NCT01701895 is registered in ClinicalTrials.gov with Prema Menezes, PhD, PA-C as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
- Lead sponsor
- Prema Menezes, PhD, PA-C
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- October 31, 2015
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1 infection